The Patent Finder

Juvaris Biotherapeutics, Inc.

Also on record
Records under this name other than the patents Juvaris Biotherapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 6 of 6 · Back to Juvaris Biotherapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,044,215Methods for the Preparation of Amphillic Nitrogen Containing Imidazolinium Derivative Compounds
Lapsed on the fee record
Ended Oct 25, 2023 · High confidence
Lapsed on the fee recordEnded Oct 25, 2023High confidence
US 8,945,590Enhancement of an Immune Response by Administration of a Cationic Lipid-DNA Complex (CLDC)
Lapsed on the fee record
Ended Feb 3, 2023 · High confidence
Lapsed on the fee recordEnded Feb 3, 2023High confidence
US 6,344,446Cationic lipid:DNA complexes for gene targeting
Term ended
Ended no later than Jun 7, 2015 · USPTO record
Term endedEnded no later than Jun 7, 2015USPTO record
US 5,705,655Amphiphilic nitrogen containing imidazolinium derivative compounds and uses
Term ended
Term ended no later than Jan 6, 2018 · Low confidence
Term endedTerm ended no later than Jan 6, 2018Low confidence
US 5,736,395Amphiphilic imidazolinium derivatives
Term ended
Term ended no later than Apr 7, 2018 · Low confidence
Term endedTerm ended no later than Apr 7, 2018Low confidence
US 5,830,878Cationic lipid: DNA complexes for gene targeting
Term ended
Term ended no later than Nov 3, 2018 · Low confidence
Term endedTerm ended no later than Nov 3, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited